White ethnics

Advancing age (greater than 60 years) Light pigmentation (white ethnicity)... 

Are Jews/Italians/Greeks/Slavs/Portuguese/Letts white So far, is the only answer whose certainty is not overstated one way or the other and any realistic progressive politics on the part of these white ethnics must now rest squarely on an understanding of both the yes (they are white) and the no (their whiteness is merely contingent) which are historically embedded in that tentative reply. The affirmative, it turns out, owes some-... 

Because black- ethnic relations lie so near the core of this entire complex of concerns, the whiteness of the white ethnic becomes once again unstable. Recounting the murder of Joseph Columbo by an African-American on Italian Unity Day, 1971, Novak wants to know, Couldn t [blacks] distinguish a fellow sufferer under Nordic prejudice from a WASP Or again, ethnics are not unaware of the peculiar forms of fear, envy, and suspicion across color lines. How much of this we learned in America by being made conscious of our olive skin, brawny backs, accents, names, and cultural quirks is not plain to us. 6... 

Although Novak was only fleetingly concerned with the status of Jews as white ethnics (more often he numbered them among the privileged and contemptuous elites), the Jewish writer Leonard Fein was perhaps even more to the point on precisely Novak s theme We are too much... 

The prevalence of hypertension differs based on age, sex, and ethnicity. As individuals become older, their risk of high blood pressure increases. Individuals 55 years of age who do not have hypertension are estimated to have a lifetime risk of 90% of eventually developing hypertension. The National Health and Nutrition Examination Survey from 1999 to 2000 indicated that hypertension is slightly more prevalent in men (30.1%) than women (27.1%). However, the prevalence increased by 5.6% in women and has remained unchanged in men from 1988 to 2000.5 Hypertension prevalence is highest in African-Americans when compared to non-Hispanic whites and Mexican-Americans.1... 

White or Asian ethnicity Positive family history of osteoporosis Female sex Advanced age... 

Anemia is a common condition, and the prevalence of anemia varies widely based on age, gender, race/ethnicity, and comorbid conditions. A study of anemia prevalence in a nationally representative sample of community-dwelling individuals describes how anemia differs across different populations.1 The prevalence of anemia in children (ages 1-16 years) was 6% to 9%, but the prevalence of anemia increases to approximately 11% in adults over age 65 years and to at least 20% in adults 85 years of age and older. Anemia is generally more common in women, particularly during their reproductive years (ages 17-49 years), when anemia occurs in over 12%, but in less than 2% of men. The same study showed that in the population over age 65, non-Hispanic whites and Mexican Americans had similar prevalence of anemia (9.0% and 10.4%, respectively), but with a prevalence of 27.8%, anemia was significantly more common in non-Hispanic blacks. 

In the United States, tuberculosis disproportionately affects ethnic minorities as compared with whites, reflecting greater ongoing transmission in ethnic minority communities. Additional tuberculosis surveillance and preventive treatment are required within these communities. 

Most breast cancers diagnosed are small tumors (less than or equal to 2 cm), and disease is localized in all racial and ethnic groups. However, blacks and other minority women have proportionally more cases of disease diagnosed at more advanced stages compared with white women. This is thought to reflect access to and use of screening mammography and timely treatment. 

Wagner etal. (1998) investigated the ethnic differences in antidepressant response to fluoxetine or placebo in 118 depressed, predominantly male, HIVpositive patients (White n = 79, Hispanic n = 17, African American n = 22). Nine Hispanic subjects (53%) dropped out of treatment making the results difficult to interpret. Among completers in the placebo arm, 80% (four out of five) of Hispanic subjects were responders as compared to 36% of African American subjects and 43% of White subjects. 

A small, flexible dose study of citalopram (dosage range = 10-40 mg/day) in 14 Hispanic and 6 non-Hispanic (non-White) depressed HIV-positive patients conducted in Miami also showed no differences in response rate or effective dose between ethnicities (Currier etal., 2004). In addition, Hispanic patients did not have a significantly higher attrition rate compared to non-Hispanics. 

A pooled analysis of 14 875 adults (Hispanic, n = 361 White, n = 10 108 African American, n = 547 Asian, n = 112) who participated in 104 double-blind, placebo-controlled paroxetine trials for mood and anxiety disorders was performed to ascertain minority group differences (Roy-Byrne et al., 2005). There were significant differences in rates of response by ethnicity (p = 0.014) with the odds of responding being lower for the Asian and Hispanic subjects compared to the African American and White subjects. There was also a higher placebo response rate in Hispanic subjects. Rapidity of response and emergence of adverse effects were similar across groups. 

---